Breaking News
Sort by:
Top Post
Roche’s Tecentriq Plus Avastin Reduced Risk of Cancer Returning in People with Certain Types of Adjuvant Liver Cancer in a Phase III Study
Roche has announced new data from the Phase III IMbrave050 study that show Tecentriq (atezolizumab) […]
CytoMed Therapeutics Announces Collaboration with MD Anderson Cancer Center
CytoMed Therapeutics, a biopharmaceutical company focused on harnessing its licensed proprietary technologies to create novel […]
Temple Therapeutics Reveals Breakthrough Findings on Ovarian Cancer at AACR 2023
Temple Therapeutics, a biotechnology company pioneering a female-focused precision medicine approach, presented new in vitro […]
Telix to Supply Bayer with Illuccix® for Global Phase III Prostate Cancer Study
Telix Pharmaceuticals today announces that it has entered into an agreement with Bayer AG (Bayer) […]
CANbridge Pharmaceuticals Appoints Jason West Vice President, Head of Gene Therapy Research
CANbridge Pharmaceuticals, a global biopharmaceutical company, with a foundation in China, committed to the research, […]
Brenus Pharma Unveils Groundbreaking Preclinical Results For STC-10101, a Promising New Drug Candidate Targeting Colorectal Cancer & Solid Tumors
Brenus Pharma announces two groundbreaking presentations on STC-1010, the company’s first drug candidate for colorectal […]
Antiva Biosciences Closes $53 Million Series E Equity Financing
Antiva Biosciences, a biopharmaceutical company developing novel, topical therapeutics for the treatment of pre-cancerous lesions […]
Junshi Biosciences Announces Primary Endpoint Met in RENOTORCH Study of Toripalimab for 1st-line Treatment of Advanced Renal Cell Carcinoma
Shanghai Junshi Biosciences, a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization […]
National Multicenter Trial Opens to Study ImmunityBio’s Tri-Ad5 Cancer Vaccines Plus N-803 to Prevent Cancer in People with Lynch Syndrome
ImmunityBio, a clinical-stage immunotherapy company, today announced the opening of a clinical trial to study […]
ImmunoGen Appoints Isabel Kalofonos as Senior Vice President and Chief Commercial Officer
ImmunoGen, a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of […]
Bridge Biotherapeutics Receives FDA Authorization to Proceed with the First-in-Human Study of BBT-207
Bridge Biotherapeutics, a clinical-stage biotech company based in South Korea and Cambridge that is advancing novel drugs for […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more